Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
PeptiMed
3120
PeptiMed
Technology
Biotechnology
Edeniq is a biomaterials and sustainable fuels innovator processing low-costcellulosic sugars and ethanol.
Suggest edits
Founded
2012
Raised
$98.2M
Follow us
Also headquartered in Madison
Exact Sciences
Venture Investors
American Family
Propeller Health
Quest Diagnostics
EatStreet
Zuku
Redox
WARF
Cellectar
Companies in the same industry
Repare Therapeutics
Indee Labs (YC W17)
Dumpling
Altius Analytics Labs
BEROCEUTICA GmbH
Integrated BioTherapeutics, Inc.
MycoWorks
Antengene Corporation
Aurealis Pharma
DNA Script
Alexa global traffic share
Twitter followers
Overview
Funding
9
Add info
Acquired by
05 May 2016
Aimetis Corp.
Latest funding
Show all
$300,000
Grant - 2016
National Cancer Institute (NCI)
$200,000
Venture capital - 2016
Location
Madison
,
United States
Headquarters
Explore Madison
businesswire
Edeniq Secures $5 Million in Growth Equity, Has 27 Plants in Cellulosic Ethanol Pipeline
FinSMEs
,
businesswire
Edeniq Raises $7m in Equity Funding
$300,000
Grant
Arizona Daily Star
Tucson's NuvOx wins $300K grant
